Brighton, United Kingdom – 12 August 2024 – Destiny Pharma plc (AIM: DEST), a clinical-stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening
Brighton, United Kingdom – 12 August 2024 – Destiny Pharma plc (AIM: DEST), a clinical-stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure life-threatening
May give investors a bigger say over fat-cat pay and takeover battles
By Harriet Dennys For The Mail On Sunday An art dealership accused of offering to launder money through the sale of a Picasso painting has gone bust. It is the latest